|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Marketing | |||||
| Product development | |||||
| General and administrative | |||||
| Goodwill impairment | |||||
| Asset impairment charges | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other (expense) income: | |||||
| Interest expense | |||||
| Interest and other income | |||||
| Foreign exchange (loss) gain | |||||
| Loss on sale of business | |||||
| Total other (expense) income | |||||
| Income before income taxes | |||||
| (Provision) benefit for income taxes | |||||
| Net income | |||||
| Net income per share attributable to common stockholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...